TGFB2 and central nervous system cancer: While the DIPG patients were younger than the non-DIPG DMG patients, no age-related changes in the TGFB2 responsiveness of high-grade pediatric glioma cells or tumor microenvironment composition in DMG have been reported to suggest the observations were in part age-related.